LEIDY CARABALLO GALVA

Concepts (20)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
938
0.780
Why?
Liver Neoplasms
2
2021
1312
0.700
Why?
Immunotherapy
1
2020
661
0.480
Why?
Immunotherapy, Adoptive
1
2020
824
0.430
Why?
Glypicans
1
2021
39
0.190
Why?
T-Lymphocytes
2
2020
1693
0.190
Why?
alpha-Fetoproteins
1
2020
131
0.160
Why?
Xenograft Model Antitumor Assays
1
2021
884
0.160
Why?
Cancer Vaccines
1
2020
177
0.150
Why?
Receptors, Antigen, T-Cell
1
2020
479
0.130
Why?
Antibodies, Monoclonal
1
2021
1010
0.130
Why?
Mice
2
2021
17557
0.070
Why?
Animals
2
2021
33853
0.050
Why?
Humans
3
2021
123280
0.040
Why?
HLA-A2 Antigen
1
2020
25
0.040
Why?
Pyrophosphatases
1
2020
19
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
62
0.040
Why?
Cross Reactions
1
2020
193
0.040
Why?
Lymphocyte Activation
1
2020
684
0.040
Why?
Cells, Cultured
1
2020
3045
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (20)
Explore
_
Similar People (60)
Explore
_